Printing and distribution services

Tender description

The Medicines and Healthcare products Regulatory Agency publishes the British Pharmacopoeia. The British Pharmacopoeia (BP) is the official collection of standards for UK medicinal products and pharmaceutical substances. Produced by the British Pharmacopoeia Commission Secretariat of the Medicines and Healthcare products Regulatory Agency, the BP makes an important contribution to public health by setting publicly available standards for the quality of medicines. Since 1864, the BP has been providing authoritative standards for medicinal products and pharmaceutical substances and it continues to play an important role in the standard-setting process worldwide. Now used in over 100 countries, the BP remains an essential reference for all individuals and organisations working within pharmaceutical research and development, manufacture and testing around the globe. The British Pharmacopoeia is published in both hard and electronic formats. The agency has a requirement for a supplier to revise, publish, market and sell the British Pharmacopoeia on behalf of the agency. The Medicines and Healthcare products Regulatory Agency is a Government Trading Fund and an Executive Agency of the Department of Health established on 1.4.2003. We have around 1 270 staff, with a total budget of approximately 150 000 000 GBP. We protect and improve the health of millions of people every day through the effective regulation of medicines and medical devices, underpinned by science and research. There are three segments to the agency's work: Medicines and Healthcare products Regulatory Agency (MHRA) Regulates medicines and medical devices, ensuring that they work, and are acceptably safe; focusing on the core activities of product licensing, inspection and enforcement, and pharmacovigilance. Clinical Practice Research Datalink (CPRD) Gives access to an unparalleled resource for conducting observational research and improving the efficiency of interventional research, across all areas of health, medicines and devices. National Institute for Biological Standards and Control (NIBSC) World leaders in assuring the quality of biological medicines through product testing, developing standards and reference materials and carrying out applied research.